logo

For the Inventor, By the Inventor

Paris, France

Reinhard Kirsch

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignee: Sanofi. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reinhard Kirsch. Retrieved from https://idiyas.com/inventor/reinhard-kirsch-adyyt850

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal3 out of 1,549 
 
Sanofi
 patents

Years Active: 2014-2016

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents
1. 9452164 - Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof (2016-09-27),
2. 9150544 - Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application (2015-10-06),
3. 8759344 - Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof (2014-06-24),

Title: Reinhard Kirsch: Innovator in Pharmaceutical Chemistry

Introduction

Reinhard Kirsch is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on various compounds. With a total of 3 patents to his name, Kirsch has demonstrated a commitment to advancing medical science.

Latest Patents

Kirsch's latest patents include groundbreaking inventions such as imidazopyridine derivatives, which involve a process for their preparation and therapeutic use. This invention relates to compounds that have potential applications in treating various medical conditions. Another significant patent is focused on sulphonylaminopyrrolidinone derivatives, which are known for their antithrombotic activity. These compounds inhibit blood clotting factors IXa and Xa, showcasing their potential as therapeutic drugs.

Career Highlights

Kirsch is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to explore and develop innovative solutions in the pharmaceutical industry. His contributions have not only advanced the field but have also paved the way for new therapeutic options for patients.

Collaborations

Throughout his career, Kirsch has collaborated with esteemed colleagues such as Gilbert Lassalle and Chantal Alcouffe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Reinhard Kirsch's work exemplifies the spirit of innovation in pharmaceutical chemistry. His patents and collaborations reflect a dedication to improving healthcare through scientific advancements. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…